What is NDC 59572-820?

59572-820 is the product NDC for Zeposia (ozanimod hydrochloride), Ozanimod hydrochloride .92 mg/1 capsule, listed with the FDA by Celgene Corporation. It has 1 package NDC, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Zeposia (Ozanimod hydrochloride).

Celgene Corporation, NDC labeler code 59572. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Zeposia?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Zeposia NDC 59572-820 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)59572-820Labeler and product segments. Claims need a package NDC.

Product NDC at billing width59572-0820Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
59572-820-30	59572082030	30 CAPSULE in 1 BOTTLE, PLASTIC (59572-820-30)Marketed from Mar 27, 2020

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Zeposia
Generic name (nonproprietary): ozanimod hydrochloride
Active ingredients: Ozanimod hydrochloride — .92 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Celgene CorporationNDC labeler code 59572
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 209899
Marketing start: Mar 27, 2020
Listing expires: Dec 31, 2027
Other FDA classes: Sphingosine 1-Phosphate Receptor Modulators (Mechanism)
Identifiers: Product ID 59572-820_4f94fc7c-c65f-6879-e063-6294a90a8217SPL ID 4f94fc7c-c65f-6879-e063-6294a90a8217SPL set ID 93ce2fab-edfb-4804-8074-963071de51e4RxCUI 2288406, 2288412, 2288414, 2288416, 2288418, 2288420, 2288430, 2288431, 2288432, 2288433, 2642213, 2642214UNII 3UPR33JAAM
Pharmacologic class: Sphingosine 1-phosphate Receptor Modulator

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N459572082030 followed by a unit qualifier and the quantity

Package 59572-0820-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 16, 2026.

Indications (excerpt from the label)

ZEPOSIA is indicated for the treatment of: relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. moderately to severely active ulcerative colitis (UC) in adults. ZEPOSIA is a sphingosine 1-phosphate receptor modulator indicated for the treatment of: Relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. ( 1 ) Moderately to severely active ulcerative colitis (UC) in adults. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 59572-820

What is NDC 59572-820?: 59572-820 is the product NDC for Zeposia (ozanimod hydrochloride), Ozanimod hydrochloride .92 mg/1 capsule, listed with the FDA by Celgene Corporation. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Zeposia (Ozanimod hydrochloride).
What is the active ingredient?: Ozanimod hydrochloride.
Who is the labeler?: Celgene Corporation, NDC labeler code 59572. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Zeposia?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other NDCs under NDA 209899

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 209899
Product	Strength	Form · route	Labeler	Product NDC
ZEPOSIA 7-Day Starter Packozanimod hydrochloride	—	Kit	Celgene Corporation	59572-810
ZEPOSIA Starter Kitozanimod hydrochloride	—	Kit	Celgene Corporation	59572-890

Zeposia (Ozanimod hydrochloride) NDC 59572-820